Piramal Group's private equity to raise $185 mn in new fund
Investors have stepped up ploughing money into the healthcare sector in India, home to more than 1.2 billion people, betting on steadier returns than in other businesses that have been hit by an economic slowdown. "It's a defensive sector and is recession-proof," IndiaVenture Chairman A.K. Purwar said. "On top of that, we have our parent group's strength to leverage and do better value addition."
IndiaVenture currently manages about 3.7 billion rupees. Private equity investments in Indian healthcare have nearly quadrupled to $520.36 million so far this year from $137.41 million in the same period a year ago.
In comparison, private equity investments across all sectors in India have fallen 17.5 percent to $3.26 billion from $3.95 billion during the same period last year, the data showed.
"We are about to start formal marketing of the fund," said Purwar, a former chairman of top lender State Bank of India .
The bulk of the fund would be raised from India, while global investors would be tapped for about 20 percent, he said. Piramal Enterprises, controlled by billionaire Ajay Piramal, is one of India's leading healthcare firms. It sold its India formulations business to U.S.-based Abbott Laboratories for $3.7 billion in 2010.
Be the first to comment.